Versions Compared

Old Version 22

changes.mady.by.user Rebecca Baker

Saved on

compared with

New Version 23

changes.mady.by.user Rebecca Baker

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Dataset wrap
Namepr
Rowcaps

Row 1:

Shows a cardiac MRI for subject participant 201.

Row 2:

Shows a cardiac MRI for subject participant 202 with a different MRI machine. The time of the procedure was not available so only the date is shown in the PRSTDTC variable.

Dataset2
Row

STUDYID

DOMAIN

USUBJID

SPDEVID

PRSEQ

PRREFID

PRLNKID

PRTRTPRLOC

PRFAST

PRSTDTC

1

DMD-LGE

PR

201

ABC001

1

12345678

04

CARDIAC MAGNETIC RESONANCE IMAGINGCARDIAC WALL

Y

2023-07-01T0801T09:5515:00

2

DMD-LGE

PR

202

ABC002

1

98765432

05

CARDIAC MAGNETIC RESONANCE IMAGINGCARDIAC WALL

N

2020-07-02T10:05:0002

The Cardiovascular System Findings (CV) dataset contains physiological and morphological findings related to the cardiovascular system, including the heart, blood vessels and lymphatic vessels. The findings from the CMR procedure for LGE are noted in this example. If LGE was not performed, it would not appear in the dataset.

Dataset wrap
Namecv
Rowcaps

Row 1:

Shows the late gadolinium enhancement (LGE) is positive for the overall Left Ventricle for participant 201.

Row 2:

Shows the late gadolinium enhancement (LGE) overall Left Ventricle percentage is 40% for participant 201.

Rows 3-18

Shows the segmental late gadolinium enhancement (LGE) values for each of the left ventricle segments for participant 201.

Row 19:

Shows the total

Rows 1-6:

Show the late gadolinium enhancement (LGE) is positive and affecting 4 segments with corresponding percentage for each segment segments for participant 201.

Rows 20-23:

Shows the segmental late gadolinium enhancement (LGE) percentage for each of the positive LGE segments for participant 201. 

Row 7:

Shows the late gadolinium enhancement (LGE) is negative for participant 202.

Dataset2
Row

STUDYID

DOMAIN

USUBJID

CVSEQ

CVLNKID

CVTESTCD

CVTEST

CVORRES

CVORRESU

CVSTRESC

CVSTRESN

CVSTRESU

CVLOC

CVMETHOD

CVANMETH

VISITNUM

VISIT

CVDTC

1DMD-LGECV201104LGELATE GADOLINIUM ENHANCEMENT

POSITIVE


POSITIVE



LEFT VENTRICLECARDIAC MAGNETIC RESONANCE IMAGING
1SCREENING2023-07-01
2DMD-LGECV201204TLGEPRTOTAL LATE GADOLINIUM ENHANCEMENT PERCENTAGE

40

%

40

40%LEFT VENTRICLECARDIAC MAGNETIC RESONANCE IMAGING
1SCREENING2023-07-01
3DMD-LGECV
LATE GADOLINIUM ENHANCEMENT (# of segments)
201304SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENTNEGATIVE

NEGATIVE



LEFT VENTRICULAR BASAL ANTERIOR SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING



4DMD-LGECV201404SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

POSITIVE


POSITIVE



LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING



5DMD-LGECV201504SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

POSITIVE


POSITIVE



LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING



6DMD-LGECV201604SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR BASAL INFERIOR SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING



7DMD-LGECV201704SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING



8DMD-LGECV201804SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR ANTEROLATERAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING



9DMD-LGECV201904SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR MID ANTERIOR SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING



10DMD-LGECV2011004SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

POSITIVE


POSITIVE



LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING



11DMD-LGECV2011104SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

POSITIVE


POSITIVE



LEFT VENTRICULAR INFEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING



12DMD-LGECV2011204SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR MID INFERIOR SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING



13DMD-LGECV2011304SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR MID INFEROLATERAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING



14DMD-LGECV2011404SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR ANTEROLATERAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING



15DMD-LGECV2011504SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR APICAL ANTERIOR SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING



16DMD-LGECV2011604SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR APICAL SEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING



17DMD-LGECV2011704SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR APICAL INFERIOR SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING



18DMD-LGECV2011804SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR APICAL LATERAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING



19DMD-LGECV2011904TLGETOTAL LGE SEGMENTS 

4


4

4
LEFT VENTRICLECARDIAC MAGNETIC RESONANCE IMAGING
1SCREENING2023-07-01
3
20DMD-LGECV201
3
2004LGEPERLATE GADOLINIUM ENHANCEMENT PERCENTAGE
20

40

%
20

40

20
40%LEFT VENTRICULAR BASAL
ANTERIOR
ANTEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING
1SCREENING2023-07-01
4
21DMD-LGECV201
4
2104LGEPERLATE GADOLINIUM ENHANCEMENT PERCENTAGE
30

20

%
30

20

30
20%LEFT VENTRICULAR BASAL
ANTEROSEPTAL
INFEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING
1SCREENING2023-07-01
5
22DMD-LGECV201
5
2204LGEPERLATE GADOLINIUM ENHANCEMENT PERCENTAGE

45

%

45

45%LEFT VENTRICULAR MID
INFERIOR
ANTEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING
1SCREENING2023-07-01
6
23DMD-LGECV201
6
2304LGEPERLATE GADOLINIUM ENHANCEMENT PERCENTAGE
50

20

%
50

20

50
20%
RIGHT
LEFT VENTRICULAR
MID INFERIOR
INFEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING
1SCREENING2023-07-01
7
24DMD-LGECV2021
05
04LGELATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICLECARDIAC MAGNETIC RESONANCE IMAGING
1SCREENING2023-07-01

The Procedure Agent (AG) dataset is an interventions domain that contains the agents administered to the participant as part of a procedure or assessment. The AG dataset shows the timing of the Gadolinium based contrast, GD-DOTA.  Participant 202 did not have the time the contrast was given available so only the date is represented in AGSTDTC variable.

Dataset wrap
Nameag
Dataset2

Row

STUDYID

DOMAIN

USUBJID

AGSEQ

AGLNKID

AGTRT

AGCAT

AGDOSE

AGDOSU

AGDOSFRM

AGROUTE

AGSTDTC

1

DMD-LGE

AG

201

1

04

Gd-DOTA

CONTRAST AGENT

8

mL

SOLUTION

INTRAVENOUS

2023-07-01T08:45:00

12

DMD-LGE

AG

202

12

0504

Gd-DOTA

CONTRAST AGENT

10

mL

SOLUTION

INTRAVENOUS

2023-07-05T09:55:0005